Search results
New U.S. bird-flu case is first with respiratory symptoms, CDC says
Market Watch· 6 hours agoA new human bird-flu case identified in a Michigan dairy worker is the first in the U.S. to involve...
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement...
Morning Times· 4 days agoMediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nasdaq: BNTX, "< ...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 6 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Moderna nears deal with US government to receive funding for bird flu vaccine, report says - The...
The Boston Globe· 7 hours agoModerna is nearing a deal with the US government to fund a late-stage trial of its bird flu vaccine,...
‘Cloaked’ proteins deliver cancer-killing therapeutics into cells | Cornell Chronicle
Cornell News Service· 3 days agoAn interdisciplinary collaboration has designed a way to “cloak” proteins so that they can be...
Germany's military to drop mandatory Covid-19 vaccination requirement
dpa international via Yahoo News· 1 day agoSoldiers in the German armed forces will no longer be required to present proof of coronavirus...
Germany's military to drop mandatory Covid-19 vaccination requirement
dpa international via Yahoo News· 2 days agoSoldiers in the German armed forces will no longer be required to present proof of coronavirus...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...
Explainer-What are the FLiRT COVID variants and are they more contagious?
Reuters via Yahoo News· 7 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 5 hours agoThe current COVID-19 boosters targeting the Omicron XBB.1.5 subvariant are still offering solid...